Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting
about
Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in ZebrafishGene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinomaSAAS-CNV: A Joint Segmentation Approach on Aggregated and Allele Specific Signals for the Identification of Somatic Copy Number Alterations with Next-Generation Sequencing Data.A meta-analysis of array-CGH studies implicates antiviral immunity pathways in the development of hepatocellular carcinoma.Constructing Bayesian networks by integrating gene expression and copy number data identifies NLGN4Y as a novel regulator of prostate cancer progression.CYCLOPS reveals human transcriptional rhythms in health and disease.Clinicopathologic and gene expression parameters predict liver cancer prognosis.Liverome: a curated database of liver cancer-related gene signatures with self-contained context informationA comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterationsRelatively Small Contribution of Methylation and Genomic Copy Number Aberration to the Aberrant Expression of Inflammation-Related Genes in HBV-Related Hepatocellular Carcinoma.Chronic immune activation is a distinguishing feature of liver and PBMC gene signatures from HCV/HIV coinfected patients and may contribute to hepatic fibrogenesisAberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1AWhole-genome sequencing identifies recurrent mutations in hepatocellular carcinomaDownregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis.Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.Circulating markers for prognosis of hepatocellular carcinoma.Wnt/β-catenin activation and macrophage induction during liver cancer development following steatosis.Utilizing signature-score to identify oncogenic pathways of cholangiocarcinomaA Next Generation Multiscale View of Inborn Errors of Metabolism.Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.Meta-analysis of gene expression profiles indicates genes in spliceosome pathway are up-regulated in hepatocellular carcinoma (HCC).Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.LDB2 inhibits proliferation and migration in liver cancer cells by abrogating HEY1 expression.Evidence for widespread dysregulation of circadian clock progression in human cancer.A Significant Regulatory Mutation Burden at a High-Affinity Position of the CTCF Motif in Gastrointestinal Cancers.Integrative functional genomic delineation of the cascades of transcriptional changes involved in hepatocellular carcinoma progression.Evolving-Pattern Analysis of Transient and Long-Term Biomarkers for Cancers: Hepatocellular Carcinoma as a Case.Evolving-pattern analysis of transient and long-term biomarkers for cancers: Hepatocellular carcinoma as a case.Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma
P2860
Q27310913-1180B458-012C-4BFF-B08E-3A07B498EE46Q28740309-9E689D2F-01C8-4905-84B2-DD8548832394Q31026307-AD2BCBDB-C405-406B-BF58-386E0C1B87A1Q31043530-C12499A2-0135-4EB4-AB8D-73EF879098A2Q31130674-21DC143E-C830-468F-A9F9-2A0AC337738AQ33719425-46E32324-D0DB-4C9E-A1B2-ECB4717CD92AQ34070902-6DB1B1F9-E41F-4106-99B8-53D61C0D984EQ34173509-D5EC12DB-B921-464E-812F-E7BDC36FD799Q34364398-0F827998-B8E2-43FF-A7A5-9F3EF9CA941FQ35627999-FC3CBFF2-8AC0-4DA0-B61C-18892C84AA16Q36019847-96B9C24E-90A2-4FA7-A1C7-9E6DF9145D10Q36356171-B808BF29-BCBB-42E8-B67C-983F49BDFE4AQ37138658-7E3D14BB-096C-4C1B-B18C-E49DF86080B8Q37688076-847ADFAC-9A69-4300-B3B0-B9D0A6184709Q37718419-0077AAF5-9AFE-4290-A163-10DA531A07E3Q38103946-CE93B80B-BB10-48CE-9005-923EE75417B5Q38431732-EC5D920E-6320-4DD3-8BED-89E5D0EACDC7Q38487518-CB8E2895-DA85-4597-A543-EB837742947DQ38681906-47D4DB2F-82F7-4C93-9D5C-1DE7848EC37EQ39179262-A11BB80D-11F7-484C-B718-1DC61B94D2DDQ41322632-804CB31D-60CD-4660-BBA9-D6C550E4E97DQ44395085-84F29E83-FB56-424D-8D41-6026D7289803Q47144026-84257C5B-FDBF-4E2C-8FBE-808DDCFF723FQ49396002-37C9E35D-7D4B-47D8-A74A-6697765E192DQ50853577-976C0BEA-1D66-428D-B722-5ADB52BAC47DQ53089247-777BCE80-D868-4829-91D5-B245230CEDFEQ53388123-AE920954-8F12-4FFE-98B3-8FAEC41597F2Q53615601-DB358641-5D08-4520-BCA9-9D1B5547E114Q58062853-1864E084-A1AD-4B3B-8F71-686F3235DF8E
P2860
Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Predictive genes in adjacent n ...... r cancer and may rate limiting
@ast
Predictive genes in adjacent n ...... r cancer and may rate limiting
@en
Predictive genes in adjacent n ...... r cancer and may rate limiting
@nl
type
label
Predictive genes in adjacent n ...... r cancer and may rate limiting
@ast
Predictive genes in adjacent n ...... r cancer and may rate limiting
@en
Predictive genes in adjacent n ...... r cancer and may rate limiting
@nl
prefLabel
Predictive genes in adjacent n ...... r cancer and may rate limiting
@ast
Predictive genes in adjacent n ...... r cancer and may rate limiting
@en
Predictive genes in adjacent n ...... r cancer and may rate limiting
@nl
P2093
P2860
P50
P1433
P1476
Predictive genes in adjacent n ...... r cancer and may rate limiting
@en
P2093
Andrey Loboda
Carolyn Buser-Doepner
Chun Yeung
Chunsheng Zhang
Cliona Molony
Danielle Greenawalt
Dimple Bansal
Eric E Schadt
Eugene Chudin
P2860
P304
P356
10.1371/JOURNAL.PONE.0020090
P407
P577
2011-01-01T00:00:00Z